1. Home
  2. TSN vs BGNE Comparison

TSN vs BGNE Comparison

Compare TSN & BGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSN
  • BGNE
  • Stock Information
  • Founded
  • TSN 1935
  • BGNE 2010
  • Country
  • TSN United States
  • BGNE Cayman Islands
  • Employees
  • TSN N/A
  • BGNE N/A
  • Industry
  • TSN Meat/Poultry/Fish
  • BGNE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSN Consumer Staples
  • BGNE Health Care
  • Exchange
  • TSN Nasdaq
  • BGNE Nasdaq
  • Market Cap
  • TSN 20.9B
  • BGNE 21.0B
  • IPO Year
  • TSN N/A
  • BGNE 2016
  • Fundamental
  • Price
  • TSN $64.32
  • BGNE $189.23
  • Analyst Decision
  • TSN Hold
  • BGNE Buy
  • Analyst Count
  • TSN 10
  • BGNE 7
  • Target Price
  • TSN $61.60
  • BGNE $247.07
  • AVG Volume (30 Days)
  • TSN 2.5M
  • BGNE 281.8K
  • Earning Date
  • TSN 11-12-2024
  • BGNE 11-12-2024
  • Dividend Yield
  • TSN 3.05%
  • BGNE N/A
  • EPS Growth
  • TSN N/A
  • BGNE N/A
  • EPS
  • TSN 2.25
  • BGNE N/A
  • Revenue
  • TSN $53,309,000,000.00
  • BGNE $3,351,304,621.00
  • Revenue This Year
  • TSN $2.47
  • BGNE $969.39
  • Revenue Next Year
  • TSN $2.39
  • BGNE $24.79
  • P/E Ratio
  • TSN $28.59
  • BGNE N/A
  • Revenue Growth
  • TSN 0.81
  • BGNE 50.22
  • 52 Week Low
  • TSN $46.51
  • BGNE $126.97
  • 52 Week High
  • TSN $66.88
  • BGNE $248.16
  • Technical
  • Relative Strength Index (RSI)
  • TSN 71.91
  • BGNE 31.72
  • Support Level
  • TSN $61.06
  • BGNE $189.60
  • Resistance Level
  • TSN $65.95
  • BGNE $209.29
  • Average True Range (ATR)
  • TSN 1.36
  • BGNE 6.42
  • MACD
  • TSN 0.70
  • BGNE -2.10
  • Stochastic Oscillator
  • TSN 80.46
  • BGNE 9.19

About TSN Tyson Foods Inc.

Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, each comprising about one-third of US sales. Prepared foods constitute roughly 20% of sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 5% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.

About BGNE BeiGene Ltd.

BeiGene Ltd is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. BeiGene's key cancer treatments are BRUKINSA (zanubrutinib), Bruton's tyrosine kinase (BTK) inhibitor, and TEVIMBRA (tislelizumab), an anti-PD-1 antibody. In addition, it has a diverse pipeline of novel therapeutics focusing on a range of malignancies, including AML, MDS, multiple myeloma, lung, gastrointestinal, breast, and gynecologic cancers. The Company operates in one segment: pharmaceutical products and is primarily located in the U.S. and the PRC. Key revenue is generated from the U.S.

Share on Social Networks: